查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547701

全球鉅细胞病毒治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Cytomegalovirus Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

全球鉅细胞病毒治疗市场需求预计将从 2023 年的 5.0222 亿美元达到近 9.6448 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.52%。

鉅细胞病毒治疗用于因疱疹家族病毒透过血液、唾液、尿液、精液和母乳等体液传播而感染的患者。对于健康的儿童和成人来说，通常不需要鉅细胞病毒治疗，并且他们无需药物即可康復。但新生儿和免疫力较弱的人在出现鉅细胞病毒感染症状时需要接受治疗。治疗方法主要取决于征兆、症状和严重程度。可以减缓病毒繁殖的抗病毒药物是最常见的治疗类型。用于治疗和预防 CMV 的新药物和疫苗正在不断研究。

市场动态

CMV 感染和其他几种病毒感染盛行率的上升将是推动该市场成长的关键趋势。由于这种透过体液传播的高传染性病毒迅速传播，全球器官移植和输血数量的增加可以促进该市场的成长。民众对感染的认识不断提高，政府和私人组织增加资金支持治疗该感染的临床试验，将有利于市场成长。这种鉅细胞病毒能够感染所有年龄层的人，并产生更严重的症状，影响眼睛、肺部、肝臟、食道、胃和肠道，这将进一步促进市场成长。高昂的治疗成本和病毒在体内长期潜伏的能力将是阻碍该市场成长的主要限制因素。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球鉅细胞病毒治疗市场的每个细分市场进行了包容性评估。鉅细胞病毒治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

鉅细胞病毒治疗市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依疾病类型

  • 爱滋病
  • 肝炎
  • 流感
  • 结核病
  • 疟疾
  • HPV病毒

按最终用途

  • 医院
  • 诊所
  • 其他的
  • 传染病治疗

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲鉅细胞病毒治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。鉅细胞病毒治疗市场的主要参与者包括吉利德科学公司、Chimerix、Clinigen Group PLC、默克公司、F. Hoffmann-La Roche Ltd、Fresenius Kabi、Genentech Inc.、Teva Pharmaceuticals Inc、Mylan NV、Thermo Fisher Scientific 、武田製药、辉瑞。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：鉅细胞病毒治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按疾病类型分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球鉅细胞病毒治疗市场分析：依疾病类型

  • 依疾病类型概述
  • 历史和预测数据
  • 依疾病类型分析
  • 爱滋病
  • 肝炎
  • 流感
  • 结核病
  • 疟疾
  • HPV病毒

第 6 章：全球鉅细胞病毒治疗市场分析：依最终用途分类

  • 按最终用途概述
  • 历史和预测数据
  • 按最终用途分析
  • 医院
  • 诊所
  • 其他的
  • 传染病治疗

第 7 章：全球鉅细胞病毒治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：鉅细胞病毒治疗公司的竞争格局

  • 鉅细胞病毒治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Gilead Sciences
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Chimerix
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Clinigen Group PLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Fresenius Kabi
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Genentech Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Teva Pharmaceuticals Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Mylan NV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Takeda Pharmaceuticals
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11213855

The global demand for Cytomegalovirus Treatment Market is presumed to reach the market size of nearly USD 964.48 Million by 2032 from USD 502.22 Million in 2023 with a CAGR of 7.52% under the study period 2024-2032.

Cytomegalovirus treatment is used in patients suffering an infection due to a virus belonging to the herpes family transmitted through body fluids like blood, saliva, urine, semen, and breast milk. Cytomegalovirus treatment is generally not necessary for healthy children and adults, and they recover without medication. But newborns and people who have weakened immunity undergo treatment when they are experiencing symptoms of CMV infection. The treatment method primarily depends on the signs, symptoms, and severity. Antiviral medications that can slow the reproduction of the virus are the most common type of treatment. New drugs and vaccines to treat and prevent CMV are continually being researched.

MARKET DYNAMICS

The rising prevalence of CMV infections and several other viral infections will be the crucial trend propelling this market's growth. An increase in the number of organ transplants and blood transfusion carried out worldwide can boost this market's growth due to the rapid spread of this highly infectious virus transmitted through body fluids. Growing public awareness about the infection and increased funding from the government and private organizations to support clinical trials for treating the same will benefit market growth. This CMV's nature to infect people of all age groups and have more severe symptoms affecting the eyes, lungs, liver, esophagus, stomach, and intestines will further enhance market growth. The high treatment costs and the virus's ability to remain latent within the body over long periods will be the main restraints hindering this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cytomegalovirus Treatment. The growth and trends of Cytomegalovirus Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cytomegalovirus Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease Type

  • HIV
  • Hepatitis
  • Influenza
  • TB
  • Malaria
  • HPV

By End Use

  • Hospitals
  • Clinics
  • Others
  • Infectious Disease Therapeutics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cytomegalovirus Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cytomegalovirus Treatment market include Gilead Sciences, Chimerix, Clinigen Group PLC, Merck & Co. Inc, F. Hoffmann-La Roche Ltd, Fresenius Kabi, Genentech Inc., Teva Pharmaceuticals Inc, Mylan N.V, Thermo Fisher Scientific, Takeda Pharmaceuticals, Pfizer. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CYTOMEGALOVIRUS TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease Type
    • 3.7.2 Market Attractiveness Analysis By End Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CYTOMEGALOVIRUS TREATMENT MARKET ANALYSIS BY DISEASE TYPE

  • 5.1. Overview By Disease Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Disease Type
  • 5.4. HIV Historic and Forecast Sales By Regions
  • 5.5. Hepatitis Historic and Forecast Sales By Regions
  • 5.6. Influenza Historic and Forecast Sales By Regions
  • 5.7. TB Historic and Forecast Sales By Regions
  • 5.8. Malaria Historic and Forecast Sales By Regions
  • 5.9. HPV Historic and Forecast Sales By Regions

6. GLOBAL CYTOMEGALOVIRUS TREATMENT MARKET ANALYSIS BY END USE

  • 6.1. Overview By End Use
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By End Use
  • 6.4. Hospitals Historic and Forecast Sales By Regions
  • 6.5. Clinics Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions
  • 6.7. Infectious Disease Therapeutics Historic and Forecast Sales By Regions

7. GLOBAL CYTOMEGALOVIRUS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CYTOMEGALOVIRUS TREATMENT COMPANIES

  • 8.1. Cytomegalovirus Treatment Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CYTOMEGALOVIRUS TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Gilead Sciences
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Chimerix
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Clinigen Group PLC
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Merck & Co. Inc
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. F. Hoffmann-La Roche Ltd
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Fresenius Kabi
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Genentech Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Teva Pharmaceuticals Inc
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Mylan N.V
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Thermo Fisher Scientific
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Takeda Pharmaceuticals
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Pfizer
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease Type (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Hepatitis Market Sales By Geography (USD MN)
  • Influenza Market Sales By Geography (USD MN)
  • TB Market Sales By Geography (USD MN)
  • Malaria Market Sales By Geography (USD MN)
  • HPV Market Sales By Geography (USD MN)
  • Analysis By End Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Infectious Disease Therapeutics Market Sales By Geography (USD MN)
  • Global Cytomegalovirus Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cytomegalovirus Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Cytomegalovirus Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease Type
  • Market Attractiveness Analysis By End Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease Type (USD MN)
  • HIV Market Sales By Geography (USD MN)
  • Hepatitis Market Sales By Geography (USD MN)
  • Influenza Market Sales By Geography (USD MN)
  • TB Market Sales By Geography (USD MN)
  • Malaria Market Sales By Geography (USD MN)
  • HPV Market Sales By Geography (USD MN)
  • Global Market Analysis By End Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Infectious Disease Therapeutics Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.